Blossom publishes several articles per week that provide commentary on the developing field of psychedelics as medicine. Here we analyse the latest research, provide overviews of research areas, and conduct interviews with leading psychedelic figures.
In the Research Briefing of January 10th: 1) Psilocybin can be administered safely for up to six people simultaneously 2) An Open Science approach toward MDMA synthesis 3) Nitrous Oxide could be the next antidepressant
December was another busy month in the world of psychedelic research as 2021 came to a close. The benefits of microdosing remain in dispute, the use of virtuality reality in tandem with psychedelics is further discussed, while we simultaneously gained further insight as to how different psychedelics work in the brain for different disorders, through both experiments and reviews.
To better understand the science of psychedelics, and how we can make the bridge to implementing them in practice, Blossom is conducting a series of interviews with psychedelic scientists. Our editor-at-large, George Fejer, speaks to David Glowacki, one of the world's leaders in the use of virtual reality applied to scientific simulation and visualization.
Microdosing is becoming more popular every day. From Hollywood to small towns all across the word. Is there scientific merit to it, or all placebo? And does a new paper prove the benefits of microdosing?
How can we marry psychedelic capitalism & reciprocity? | Blossom speaks to Woven Science on their approach to indigenous communities, how they can give back, and provide a template for others to do so.
November proved to be another productive month for psychedelic research. A variety of surveys looked at how psychedelics alter beliefs, reduce opioid use, and the effects of microdosing. A finished Phase I trial clear 5-MeO-DMT for the next step, cannabis intensifies a psychedelic experience, and psychedelics may help with Alzheimer's.
Blossom provides timely and timeless information on psychedelics as medicine. Our blogs, articles, and interviews help contextualize this quickly developing field of psychedelic research and how this will be implemented.
Become a psychedelic insider!
With a free Blossom membership you will always be in the know.
📰 Weekly newsletter about the psychedelic research
✔️ Unlimited access to our database and original articles